Sales decline 9.63% to Rs 313.54 crore
Net loss of Solara Active Pharma Sciences reported to Rs 10.10 crore in the quarter ended September 2025 as against net profit of Rs 8.01 crore during the previous quarter ended September 2024. Sales declined 9.63% to Rs 313.54 crore in the quarter ended September 2025 as against Rs 346.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales313.54346.95 -10 OPM %11.0817.67 -PBDT14.3933.35 -57 PBT-10.108.01 PL NP-10.108.01 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
